VentriPoint Diagnostics Ltd. VPT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.37% | 26.57% | 81.07% | 40.48% | 10.21% |
| Total Depreciation and Amortization | -2.73% | 3.81% | 0.91% | -1.75% | -4.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.48% | -84.29% | -2,414.04% | -74.48% | 307.46% |
| Change in Net Operating Assets | -93.52% | -95.60% | -115.44% | 1,500.00% | 32.04% |
| Cash from Operations | -9.35% | -102.85% | 16.51% | 86.28% | 50.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -55.00% | -93.44% | 113.36% | -101.47% | -91.11% |
| Total Debt Repaid | 0.00% | 0.00% | -3.06% | -3.06% | -3.06% |
| Issuance of Common Stock | 115.08% | 1,545.88% | -84.54% | -99.77% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 99.56% | 16.42% | 100.00% |
| Cash from Financing | 77.61% | 28.77% | -16.43% | -114.88% | -60.54% |
| Foreign Exchange rate Adjustments | -100.46% | -125.00% | 93.87% | -245.61% | 741.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.49% | -50.86% | 74.02% | 8.33% | -48.13% |